Download presentation
Presentation is loading. Please wait.
Published byBrandon Randall Modified over 8 years ago
1
Progress Update/Disbursement Request (PU/DR) forms: Training slide library May 2011
2
Slide 2 Training Slide Library Objectives To support the roll-out of revised Progress Update/Disbursement Request (PU/DR) forms released in February-March 2011. To provide a comprehensive set of training slides, designed either for self-study, or for selected use by trainers and workshop facilitators, for adaptation to different training needs. The PU/DR form and guidelines in English, French, Spanish and Russian are available on: http://www.theglobalfund.org/documents/lfa/LFA_PUDR_Guidelines_ en.pdf http://www.theglobalfund.org/documents/lfa/LFA_PUDR_Guidelines_ en.pdf
3
Slide 3 The PU/DR training slides aim to increase participant understanding of: The central role of Progress Update/Disbursement Request (PU/DR) forms, within the Global Fund’s performance based funding system, and the grant management cycle. The Global Fund’s reporting requirements which are part of the disbursement process, illustrated through working examples. The format and functionality of the Excel workbook used for PU/DR reporting, with emphasis on new sections and fields. Knowledge of the Global Fund Grant Rating Methodology is important for the completion of the PUDR Form. For a summary of the methodology please refer http://www.theglobalfund.org/en/performancebasedfunding/methodol ogy/?lang=en http://www.theglobalfund.org/en/performancebasedfunding/methodol ogy/?lang=en Specific learning points
4
Slide 4 Performance based funding lies at the heart of the Global Fund’s business model. Under this model, disbursement of grant funds is subject to verification and checks of both financial and programmatic information presented by the PR. Every year the Global Fund makes over 1,000 disbursement decisions, based on specific programmatic and financial information, gathered through Progress Update/ Disbursement Request (PU/DR) forms. The PU/DR forms are the most used in the Global Fund. Their principal function is to manage risks, set a grant rating and set a recommended disbursement amount. They are the cornerstone of Performance Based Funding, helping to ensure funds are effectively and efficiently used for delivery of life saving services. Principal Role of PU/DR forms
5
Slide 5 PU/DR forms and Grant Management 4. Data used in Grant Renewal cumulative and trend data input to Phase 2/Periodic Reviews PU/DR forms 5. Data used in new Proposal Development: source for CCM and TRP 2. Data used for grant implementation and oversight Management of risks through Management Letters 1. Data based on Grant Agreement Performance Framework + Summary Budget templates + Conditions Precedent (CPs) and/or Special Conditions (SPs) 1. Data based on Grant Agreement Performance Framework + Summary Budget templates + Conditions Precedent (CPs) and/or Special Conditions (SPs) 3. Data used for disbursement decision- making grant rating and recommended amount set by LFA-FPM/Country Team
6
Slide 6 Background of PU/DR revision ■The old country reporting forms for disbursements (PU/DR) had been in use since early 2006. Modifications to the forms became necessary to address issues and risks identified in the past five years : -insufficient guidelines; -lack of systematic tracking of progress against Management Actions; -inadequate focus on pharmaceutical / health products management; -misalignment of PR/LFA reporting forms with DDMFs and the Rating Methodology; -limited visibility on usage of funds at SR level; -no forms / guidelines in languages other than English. In 2009/2010, a cross-functional working-group from the Secretariat worked on PU/DR revision. The final forms and guidelines are a product of extensive internal and external consultations with PRs and LFAs, including pilot tests in 6 countries. Objective of PU/DR revision: Facilitate country reporting and improve information basis to support grant oversight, risk identification and disbursement decision-making.
7
Slide 7 Annex on SR financials (discretionary use) Annex on SR financials (discretionary use) Bank Details (discretio nary use) Bank Details (discretio nary use) LFA Findings and Recommendations LFA Findings and Recommendations Cash Reconciliation /DR Enhanced Financial Reporting (annual) Cash Request/ Final DR Overall Performance Procurement and Supply Management Total PR Cash Outflow Total PR Cash Outflow Programmatic Progress Structure and contents of revised PU/DR Grant Management 2 34 5 Excel workbook in two chapters: ‘PR pages’ + ‘LFA pages’. PR tabs LFA tabs Excel workbook in two chapters: ‘PR pages’ + ‘LFA pages’. PR tabs LFA tabs 1 76 Checklist Evaluation of performance Setting disbursement amount
8
Slide 8 Contents: Dedicated section on Procurement and Supply Management (PSM). Extension of Secretariat’s grant rating methodology to LFAs. Integration of Enhanced Financial Reporting forms (once a year). New Annex on sub-recipient (SR) financial information, for discretionary use with high-risk grants and/or where SRs receive a substantial proportion of funds (SR financial section is not used in the period when the EFR is due). New Bank Account Details section – only to be completed for split disbursements and for cases where bank account details change Comprehensive guidelines for PR/LFAs based on current policies and reporting requirements. Overview of main modifications Usability: Improved structure. Form and guidelines in English, French, Russian, Spanish.
9
Slide 9 Phased Rollout: Optional submission of PU/DRs in new format for reporting periods ending before 30 June 2011; Mandatory submission of PU/DRs in new format for the period ending 30 th June 2011, and all subsequent periods. PU/DR reporting timelines and rollout plan Reporting schedule: PR LFA : within 45 days from the end of the reporting period (60 days with EFR) LFA Global Fund: within 10 work days from the receipt of PR form (13 work days with EFR) The new form and guidelines were distributed to all PRs and LFAs in February- March 2011. Excel version of Grant Rating Tool was also shared with LFA.
10
Slide 10 LFA verification of PR reporting (1) LFA verification of PR reporting needs to be tailored to country and grant risks. Approach to verification is recommended to be reviewed at least annually and agreed upfront between the LFA and the Secretariat. The approach needs to take into consideration: risks identified in the LFA Country/PR Risk Assessment* PR/SR organization, operating characteristics, accounting and control systems; role of SRs and SSRs in program implementation, and PR systems for management and oversight; type of program activities financed by Global Fund, and inherent risks involved; nature of program assets, liabilities and expenditures; knowledge from prior verification work. * The ToR for the Country/PR Risk assessment is on our website under the section ‘Risk Management’: http://www.theglobalfund.org/en/lfa/documents/
11
Slide 11 LFA Verification of PR reporting (2) Typical examples of verification procedures which address identified risks (including fraud): review of PR’s internal control procedures; spot-checks of warehouse facilities, service delivery points, bed-net distribution, etc; expenditure review of specific SR financials; verification of a larger sample of invoices; procurement reviews, e.g. tender processes, procurement of vehicles; in-depth verification of high-risk activities e.g. cash payments, per diems at training events.
12
Slide 12 Completing the PU/DR forms, section by section
13
Slide 13 Legend used for inputting tips/ functionality PR Drop- down List New Field Blue shaded cells in the training library indicate fields from which data are automatically exported to the corresponding LFA forms. Smiley face indicates fields with drop-down pick-lists (easy selection of specific options) LFA Grey shaded fields in LFA forms, import data from corresponding PR sheets. New fields in the revised PU/DR forms colored yellow in slide screen shots Pink shaded cells in LFA sheets where LFA has modified PR data
14
Slide 14 Section 1: Programmatic Progress Overview Covers reporting of progress for: Impact/Outcome indicators (sub-section 1A) - important to record for grant renewal decisions. Programmatic Indicators (sub-section 1B) Analysis of data quality and reporting issues (sub-section 1C) summarises issues which may have impacted reporting on programmatic indicators. Only those Impact/Outcome indicators should be listed that are (1) due for reporting and (2) reporting on which is overdue from the previous periods. In contrast, all Programmatic indicators should be listed. Data on baselines and targets for all indicators should be taken from the latest approved Performance Framework. Includes actual results, updates on data collection methods, and comments on variance between intended targets and results.
15
Slide 15 PR_Programmatic Progress_1A (Impact/Outcome) Inputting tips PROGRESS UPDATE Progress Update - Reporting Period: Cycle:Number: Progress Update - Period Covered: Beginning Date: End Date: DISBURSEMENT REQUEST Disbursement Request - Disbursement Period: Cycle: Number: Disbursement Request - Period Covered: Beginning Date: End Date: A. Impact / Outcome Indicators Impact / Outcome Indicator Description Baseline (if applicable) Year of Target Intended Target Report Due Date Actual Result Data Source of Results Comments on results on Impact/Outcome indicators and data sources, and any other comments ValueYear Select --- -- - --- -- - --- -- - --- -- - The PU number is based on cumulative PU/DR history, and should be sequential. May not correspond to period numbers in Performance Framework. This should be PU number + 1 i.e. quarter, semester, annual, other These header fields export data automatically to subsequent sheets This information is based on the latest performance framework (PF). Values input by the PR will export to LFA sheet. Any LFA verified changes will turn relevant cell/s in the LFA sheet salmon pink
16
Slide 16 PR_Programmatic Progress_1B (Programmatic) Inputting tips B. Programmatic Indicators Objve No. Indicator No. Indicator DescriptionTied To Targets cumulative ? Top 10 ? Baseline Intended Target to date Actual Result to date % achievement Reasons for programmatic deviation ValueYear X % Is not calculated automatically. Formula to be entered by PR/LFA depending on the indicator value type (numeric vs. Numerator/Denominator/%) This may be re- calculated in the LFA sheet, based on verified results these values should correspond to values in the Performance Framework
17
Slide 17 Programmatic Indicators % achievement of Programmatic indicators plays an important role in disbursement decision-making. It is very important to explain well reasons for under- performance and outline the corrective actions. Significant overperformance needs to be explained as well and, if applicable, rationale for continuation of activities included. The LFA should comment on reasons for under-/over- perfomance and corrective actions. Unlike the scope of verification on Impact/Outcome indicators, LFAs are expected to conduct a thorough assessment of achievement of Programmatic indicators. For further detail, refer to PU/DR guidelines Section 1. Section 1: Programmatic Progress Important Impact / Outcome Indicators PR should provide explanation in cases of delays in reporting or when there are changes to the data source of results from the originally anticipated data source. The scope of LFA comments on Impact/Outcome indicators is limited to assessing status of reporting on baselines and results (e.g. whether or not a behavioral survey has been conducted) and verifying data source.
18
Slide 18 Contains PR’s comments and LFA’s verification on: 2A fulfillment of CPs and/or special conditions under the grant agreement or subsequent implementation letters; 2B progress on implementation of outstanding management actions from previous disbursements; 2C annual grant reporting requirements. Such as Enhanced Financial Reporting (EFR) and PR Audit reporting. Important: PU/DR reporting on CPs and SCs should cover the conditions that are due for fulfilment or outstanding from previous periods and not all conditions. Section 2: Grant Management Overview
19
Slide 19 The PR and LFA should include the precise number of the CP as per the grant agreement/ Implementation letter, and for management actions reference the date and # of GF management letter/s. For unfulfilled management actions or conditions, reasons should be clearly explained, and timelines given for expected completion. For further detail, refer to PU/DR guidelines Section 2. Section 2: Grant Management Inputting tips Points for specific attention of PR, LFA and Secretariat (excerpts from the guidelines) ‘If a CP / special condition that was previously fulfilled is reopened due to new circumstances, and the issue addressed by this condition is considered critical, the issue should be disclosed in the LFA Findings and Recommendations Section. At the discretion of the FPM, the issue may be followed up through the management actions assigned by the Global Fund to PR.’ ‘Some special conditions may apply to more than one period of grant implementation (e.g. condition on counterpart financing). Their fulfilment during one period does not automatically imply fulfilment in subsequent periods. The LFA will verify that the status of such conditions is reported by the PR during each period concerned.’
20
Slide 20 Update on PR’s actual expenditure against budget, for the period covered by the progress update, and cumulatively from beginning of grant. Financial data disaggregated by: PR’s total expenditures; disbursements to sub-recipients (but not SR expenditures!); medicines and pharmaceutical products; health products and health equipment. Explanations of variances between actual expenditure against budget. Explanations of variances in each PU/DR and reconciliation vs. EFR data, on an annual basis, are crucial in disbursement decision-making. The PR should provide a cash flow statement, the Statement of Sources and Uses of Funds (SSUF), along with the PU/DR. The SSUF should reconcile with figures reported in this section, and section 5A_Cash Reconciliation. Section 3A: Total PR Cash Outflow Overview
21
Slide 21 Actual expenditures should be reported on a cash basis i.e. based on timing of cash inflow/outflow, regardless of when goods or services are received/delivered. Total Pharmaceutical and Health Product expenditure should be based on payments to suppliers both at the PR and SR levels, including any direct payments made by the GF on behalf of the PR (incl. VPP) Expenditures are those incurred during the current reporting period and cumulatively since the beginning of the program. Special cases: SSF grants: PR should report any remaining expenditures related to liabilities assumed by the constituent grants and which has not been not reported in the last PU/DR of the constituent grant. Cumulation of budgets and expenditures should start from zero from the SSF start date. RCC grants: PR should not cumulate previously reported Phase 1 and Phase 2 financial information but report from the beginning of RCC. Eligible expenditures include those incurred during the grant term, in line with the grant agreement, approved budget, procurement and supply management (PSM) plan, M&E plan, and grant closure plan, or as otherwise agreed in writing by the Global Fund. For further detail, refer to PU/DR guidelines Section 3A. Section 3A: Total PR Cash Outflow Important
22
Slide 22 Please select currency used under tab PR_Programmatic Progress _1A Budget for Reporting Period Actual Cash Outflow for Reporting Period Variance Reason for Variance Cumulative Budget through period of Progress Update Cumulative Actual Cash Outflow through period of Progress Update VarianceReason for Variance 1. Total PR cash outflow vs. budget 000 000 1a. PR's total expenditures 0 0 1b. Disbursements to sub- recipients 0 0 Budget for Reporting Period* Actual Cash Outflow for Reporting Period Variance Reason for Variance Cumulative Budget through period of Progress Update Cumulative Actual Cash Outflow through period of Progress Update VarianceReason for Variance 2. Total pharmaceutical & health product expenditures vs. budget 000 000 2a. Medicines and pharmaceutical products 0 0 2b. Health products and health equipment 0 0 PR_Total PR Cash Outflow_3A PR Inputting tips ‘0’ fields in grey are automatically calculated based on inputs rows 1a. 1b. 2a. and 2b … Should correspond to the latest approved budget amount, as per Grant Agreement or Implementation Letter Cumulative amounts should reflect amounts from the beginning of the program, or RCC, or the beginning of the current implementation period for consolidated grants Based on payments to suppliers. Include any direct payments made by the GF to suppliers on behalf of the PR (including Voluntary Pooled Procurement - VPP)
23
Slide 23 Section 3B: EFR + Annex on SR Financials Overview The EFR (completed annually): is integrated into PU/DR forms to encourage the use of annual expenditure data (with breakdown by categories) in disbursement decision-making. now also includes a breakdown of PR disbursements to each SR (Part E). Data collected through the EFR enables linking financial and programmatic performance, and tracks SR spending against budgets. Annex on SR financials: Provides summary of budgets, disbursements and expenditures by SR and reasons for significant variances and LFA comments on PR's overall verification efforts relating to SRs. PR should complete this Annex only upon the Secretariat’s request. Use of this Annex is at the discretion of the FPM/Country Team and is recommended for high-risk grants, or grants where SRs receive a substantial proportion of funding.
24
Slide 24 PR/LFA should remove the disease specific EFR tabs which are irrelevant to the grant undergoing reporting. The EFR review by the LFA is a review of the process, assumptions and supporting documentation used by the PR to complete the EFR, and explanations on variances (same template as before). The LFA should input its review of the EFR form, under tab LFA_EFR Review_3B. For detailed guidance on completing the EFR form/template, please see: http://www.theglobalfund.org/documents/lfa/ VerificationOfImplementation/GuidelinesForCom pletingTheEFR.pdf Section 3B: Enhanced Financial Reporting Inputting Tips
25
Slide 25 PR_Total PR Cash Outflow_3A Values in Total PR Cash Outflow, to be consistent with EFR tab Please select currency used under tab PR_Programmatic Progress _1A Budget for Reporting Period Actual Cash Outflow for Reporting Period Variance Reason for Variance Cumulative Budget through period of Progress Update Cumulative Actual Cash Outflow through period of Progress Update VarianceReason for Variance 1. Total PR cash outflow vs. budget 000 000 1a. PR's total expenditures 0 0 1b. Disbursements to sub- recipients 0 0 Budget for Reporting Period* Actual Cash Outflow for Reporting Period Variance Reason for Variance Cumulative Budget through period of Progress Update Cumulative Actual Cash Outflow through period of Progress Update VarianceReason for Variance 2. Total pharmaceutical & health product expenditures vs. budget 000 000 2a. Medicines and pharmaceutical products 0 0 2b. Health products and health equipment 0 0 Is not expected to match with Cash outflow (section 3A) as the latter shows disbursements to SRs, but not SR expenditure. Must be equal to total cumulative budget in table A in EFR form Must be equal to total cumulative disbursements in table E in EFR form Must be equal to cumulative budget and expenditure respectively, for Medicines and Pharmaceutical products in table A in EFR form Must be equal to cumulative budget and expenditure respectively, for Health Products and health equipment in table A in EFR form
26
Slide 26 Date and amount of the latest disbursement to Sub-recipients Cumulative budgets, expenditures and disbursements by SR through the end of the reporting period Explanation of significant variances (1) between cumulative budgets and expenditures and (2) between cumulative disbursements and cumulative expenditures. Cash balance through the reporting period. When the number of SRs is significant (over 10), SRs with smaller budgets (less than 50,000 USD or its equivalent) do not have to be reported separately but can be grouped together as « other SRs ». New: Annex - SR Financials
27
Slide 27 This section covers verified information on products actually received by the PR (during the reporting period and cumulatively) vs. value as stated by the PR in the Global Fund’s online Price and Quality Reporting (PQR) system. Update of information held in the PQR system, by the PR, is a pre-requisite for any disbursement decision. The PR is ultimately responsible for the accuracy and completeness of data entered. This section also includes a brief update on risks of stock-outs at central level of the grant, and challenges and other issues related to PSM of pharmaceuticals and health products. The LFA must systematically verify completeness of cumulative amounts entered by the PR in the PQR based on products received since January 2011 and comment on variances found between the values of actual receipts, against those reported by the PR in the PQR For further detail, refer to PU/DR guidelines Section 4. Section 4: Procurement and Supply Management Overview
28
Slide 28 Price and Quality Reporting (PQR) Overview The PQR tool is a web-based system, used by the Global Fund to collect transaction level procurement information. The pharmaceuticals and health products to be reported in the PQR include: pharmaceuticals: antiretrovirals (ARVs), antimalarial and anti-TB medicines; health products: insecticide-treated nets (ITNs), long-lasting insecticidal nets (LLINs), condoms and rapid diagnostic tests. The PQR is not an accounting tool. What the PR actually pays for during a given period (reported in Section 3 of the PU/DR), may not correspond to consignments received during the same period (reported in the PQR). The LFA verifies significant differences, backed with supporting documentation. If data entered are based on a cost estimate, or pro forma invoice and the final invoice differs significantly from the data entered originally i.e. over 5% difference in unit costs, the PR should update data in PQR based on the final invoice. For guidance on using the on-line Price and Quality Reporting (PQR) tool: http://www.theglobalfund.org/en/procurement/pqr/http://www.theglobalfund.org/en/procurement/pqr/
29
Slide 29 The LFA should make sure the PR has fully completed the PQR by going through all consignment documents, noting any invoices not included, verifying unit prices given, and explaining major variances in values. In grants with a major procurement component, and in cases where major risks are present, the LFA should describe the risks in the Findings and Recommendations section, and make actionable recommendations to improve forecasting and procurement. Data on value of products received (from January 2011 onwards) required to complete the LFA table, can be found in: original invoices/shipping documents for goods received, supplied by the PR. the PQR system itself (once verified), through creation of on-line reports covering a specified period. Section 4: Procurement and Supply Management LFA inputting tips
30
Slide 30 LFA_Procurement Info_4 Inputting tips PR's response LFA's response 1a. Has the PR updated the Price Quality Reporting (PQR) with the required information… 1b. Value of Pharmaceuticals and Health Products in the PQR (6 categories only) Reporting Currency PQR Product Categories Value of products received during reporting period Value of products entered by the PR and verified as correct by the LFA in the PQR during reporting period Variance Reason for Variance Cumulative value of products received since Jan 2011 Cumulative value of products verified as correct by the LFA in the PQR since Jan 2011 VarianceReason for Variance. LFA selects currency based on currency used in majority of invoices Left empty if no products received during current reporting period LFA to verify what was actually received based on invoices/ shipping documents Data in columns shaded red taken are obtained from on-line PQR system YES, NO or N/A
31
Slide 31 This section documents issues and recommendations in five key functional/management areas: 1.program management (including management of SRs); 2.financial management and systems; 3.monitoring and evaluation; 4.pharmaceutical and health product management; 5.other management issues, such as PR capacity to generate quality reports. LFA should include important issues identified in each functional area and an analysis of their immediate or anticipated adverse impact on program implementation. (ref. Step 2 of Grant Rating Methodology, PU/DR guidelines Annex 2). An issue is classified as “important” if it impacts or is likely to impact program implementation and results. The FPM/Country Team will carefully consider, and comment on LFA recommendations in the final column of this form. Instead of repeating detailed information documented in other sections (especially that provided in LFA_Grant Management_2), it is acceptable to summarise issues and cross-reference detailed information in other sections. For further detail, refer to PU/DR guidelines Section ‘LFA-specific Section: LFA Findings and Recommendations. LFA Findings and Recommendations Overview
32
Slide 32 Functional Areas Description of Identified Issues (in order of importance) LFA Recommendations (in order of importance) FPM Comments (to be completed upon receipt of the LFA- verified form) Pharmaceutical & health product management LFA_Findings&Recommendations Inputting tips Recommendations should be relevant, specific and actionable by the PR within a reasonable timeframe. Drop-down pick-list reflects five functional areas, as per previous slide. In grants with a major procurement component, absence of tracking systems for pharmaceuticals and health products should be identified as an important management issue
33
Slide 33 Provides information on changes in PR’s cash position based on: cash disbursed to PR, or payments made to third parties by Global Fund on PR’s behalf; PR expenditures and disbursements to SRs; other income received and net exchange rate gains or losses during the reporting period. Cash balances should cover all grant funds held by PR, or on behalf of PR, in all bank accounts owned and/or used by the PR, regardless of the currency denomination and physical bank location, including any grant funds held with fiduciary agents. The PR must also submit a Statement of Sources and Uses of Funds (SSUFs), linked to Sections 3 and 5. For further detail, refer to PU/DR guidelines Section 5A Section 5A: Cash reconciliation Overview
34
Slide 34 A. LFA-VERIFIED CASH RECONCILIATION FOR PERIOD COVERED BY PROGRESS UPDATE PR- reported amounts LFA-verified amounts LFA Comments (if amounts are different from those reported by the PR) 1. Cash Balance: Beginning of period covered by Progress Update 2. Cash received by the PR from the Global Fund 3.Cash disbursed to third parties by the Global Fund on behalf of the PR 4. Interest received on bank account 5. Revenue from income-generating activities 6.Other income, if applicable (e.g. income from disposal of fixed assets, tax refunds) 0 US$ 52,793 is not the PR's ‘ 7. Total PR cash outflow 460,371 8. Net exchange rate gains/losses 9. Reconciliation adjustments 10. Cash Balance: LFA_Cash Reconciliation_5A Inputting tips Less: Add: usually exceptional, such as corrections for past periods. Gains shown with minus sign, losses shown with plus. It is recommended funds be held in grant currency up to point of utilization, where local currency is devaluing. Corresponds to actual amount disbursed by the GF. Any associated bank fees are NOT deducted at this stage. If GF disbursement is received after the end date of reporting period, enter this in Section 5B line 5 as ‘cash in transit’
35
Slide 35 The disbursement request is based on forecasted expenditure for the period immediately following the progress update ( + extra ‘cash buffer’ period) and funds available from previous disbursements. Forecasted expenditures should be prepared taking into account: Program’s absorption capacity, Changes in the workplan, Changes of unit costs, Cash balance at SR level, Financial commitments, Macro-economic factors (e.g. exchange rate, inflation rate) Significant variances between the initial budget and forecasted expenditure should be explained in light of the factors above and other factors, as applicable. The PR’s disbursement request is automatically adjusted taking into account the PR’s cash balance and ‘cash in transit’. Important: Additional buffer can be requested by the PR if the next PU/DR report is due to include an EFR, or Annex on SR financials, or any other GF requirement which cannot be delivered within 45 days. An agreement in principal for requesting this buffer should be obtained from the FPM in advance. Additional buffer is not an entitlement. Decision on disbursing the additional buffer will be made upon the PU/DR review. For further detail, refer to PU/DR guidelines Section 5B. Section 5B: Disbursement Request Overview
36
Slide 36 LFA_Disbursement Recommend_5B Inputting tips B. LFA-RECOMMENDED DISBURSEMENT AMOUNT AND EXPLANATIONS 1. Period beginning date: 1-Apr- 2010 end date: 30-Sep- 2010 Approved budget amount (reported by PR): Forecasted amount (reported by PR): LFA-verified approved budget amount: 649,447 LFA-adjusted forecasted amount: 2a. Cash buffer period PR Total Forecast Period beginning: 1-Oct- 2010 end date: 31-Dec- 2010 Approved budget amount (reported by PR): Forecasted amount (reported by PR): 2b. Additional Cash buffer LFA Total Forecast Period beginning: 31-Dec- 2010 end date: LFA-verified approved budget amount: LFA-adjusted forecasted amount: PR's explanation of variance between forecasted amounts and amounts originally budgeted. LFA's explanation of any significant variance between forecasted amounts and amounts as originally budgeted. Dates calculated automatically. Normal cash buffer of 3 months. Explanations of major variances in budget vs. forecasted amounts are crucial. If the grant qualifies to request an additional buffer, the PR should select the number of months (between 1 and 3 months) for which the request is made.
37
Slide 37 PR’s self-evaluation of grant performance to date is a holistic assessment of grant’s performance, ideally a combination of quantitative ratios and qualitative information such as: cumulative burn/execution rate for the grant; cumulative disbursement amounts against targets; programmatic achievement (on all indicators, on Top 10 indicators); qualitative overview, indicating areas of strongest and weakest performance; management issues in different functional areas; any major risks which could compromise the program implementation going forward. PR/LFA comments on planned changes to the program, and external contextual factors beyond control of PR that have impacted or may impact the program performance. LFA’s overall evaluation and rating of grant performance should be based on Steps 1-3 of the Global Fund’s Grant Rating Methodology and PR’s comments. Section 6: Overall Performance Overview
38
Slide 38 A. Overall Evaluation and Rating of Grant Performance (including a summary of how financial performance is linked to programmatic achievements) Indicator rating e.g. A2 Any major management issues resulting in downgrade? YES,NO, N/A Overall Grant Rating e.g. A2 B. LFA comments on PR planned changes in the program, if any C. LFA Comments on External Factors Beyond Control of the Principal Recipients that have impacted or may impact program Section 6: Overall Performance The Indicator rating corresponds with Step 1 of the Grant Rating Methodology, Annex 2. The Overall Grant Rating as per Step 3 of the Grant Rating Methodology (ref. Annex 2 of PUDR guidelines). Critical management issues, based on LFA findings section, are taken into account [here]. There should be no difference between the two ratings, unless major management issues were identified by the LFA in Section 2
39
Slide 39 Part A consists of the LFA’s recommended disbursement amount, and whether it is within the indicative disbursement range, based on the LFA’s overall grant rating. If outside the ranges, a rationale for disbursement to be provided. Part B - a check-list of verifications carried out by the LFA. Part C - PR bank details, in case of changes or split disbursements. Part D - a summary of the LFA’s verification approach in the current PU/DR review driven by the general approach agreed upfront between the LFA and the Secretariat based on country/grant risks. Section 7: PR_Cash Request/ LFA_Disbursement Recommendation Overview
40
Slide 40 Indicative Disbursement Ranges The principle of Performance-Based Funding links grant performance (overall grant rating) to funds disbursed (indicative disbursement range). Like the Indicator Rating, the Disbursement Range is indicative. Final disbursement amounts may lie outside the indicative range due to a number of factors identified by the Country Team. INDICATIVE DISBURSEMENT RANGES Overall Grant RatingCumulative Disbursed Amount (after the disbursement) A1Exceeding expectationsAbove 95% of cumulative budget through next reporting period A2Meeting expectationsBetween 105-85% of cumulative budget through next reporting period B1AdequateBetween 55-95% of cumulative budget through the reporting period B2Inadequate but potential demonstratedBetween 25-65% of cumulative budget through the reporting period CUnacceptableBelow 35% of cumulative budget through the reporting period
41
Slide 41 Overall RatingA2 Indicative disbursement ranges by performance rating Performance ratingRange for cumulative disbursement amount A1 Exceeding expectationsAbove 95% of cumulative budget through the next reporting period A2 Meeting expectationsBetween 85-105% of cumulative budget through the next reporting period B1 Adequate Between 55-95% of cumulative budget through the next reporting period B2 Inadequate but potential demonstratedBetween 25-65% of cumulative budget through the next reporting period C Unacceptable Below 35% of cumulative budget through the next reporting period 1. Cash amount requested by the Principal Recipient from the Global Fund for next disbursement period plus one additional quarter (amount in: please select currency in 'PR_Section 1A') 3,150,520 Three million, one hundred and fifty thousand, five hundred and twenty USD 2. LFA disbursement recommendation (amount in: please select currency in 'PR_Section1A') 1,044,934 One million, forty two thousand, nine hundred and thirty four USD State the amount in words Cumulative budget through the next period of implementation (including the buffer) Cumulative disbursed amount to date (*) Cumulative disbursed after recommended disbursement (including the buffer) % range Is the recommended disbursement within the range? 10,000,000 8,755,066 9,800,000 98% Yes LFA_Disbursement Recommendation_7 Inputting tips Sum of these = Imported from Section 6 Imported from LFA tab_5B Imported from PR_Cash Request_7A_B This data is input manually based on "Disbursements in detail report (PDF)" at http://www.theglobalfund.org/docum ents/disbursementdetails.pdf http://www.theglobalfund.org/docum ents/disbursementdetails.pdf
42
Slide 42 Conclusion Quality of PU/DRs submitted to the Secretariat has a direct impact on the speed of disbursement processing and disbursement amounts. Timeliness of PU/DRs is important for ensuring continuous flow or funds and uninterrupted program implementation. For staff involved in preparation of PU/DR it is very important to read and follow the guidelines. Wherever relevant, please inform SRs in advance of the changes and expectations in terms of reporting. Please communicate proactively any training needs related to reporting requirements to the FPM / PO / Country Team members.
43
Slide 43 PU/DR – Frequent errors and omissions ■Lack of relevant Impact / Outcome indicators. ■Inconsistencies in the way results are reported vis-a-vis the way targets are set (cumulation type, ‘tied to’). ■Errors in calculation of performance for results reported as Numerator / Denominator / Percentage e.g. ■Indicator: Number and % of health facilities submitting completed and timely reports. Target: 90/100 (90%). Correctly reported result - 80/100 (80%). Performance: 80%/90% = 89%. Cible: 90/100 (90%). Incorrectly reported result - 80/90 (89%). Performance: 89%/90% = 99%. ■Insufficient explanation of causes of weak indicatorperformance, as well as indicators significantly exceeding their targets (is there Value for Money to continue these activities?) ■Lack of information on corrective actions to improve indicator performance. ■Inconsistency / lack of links between programmatic and financial information in PU/DR. ■Weak explanation of variances between expenditures vs. budgeted amounts. ■Weak justification of significant differences between forecasts vs. budgets. Often, forecasted expenditure is not done based on up-to-date workplans, as it should be, and does not take into account cash balances at the SR level. ■Insufficient attention given to fulfilling conditions and management actions. ■Weaknesses in completing Overall Performance.
44
Some completed examples of the form The following handouts are intended as an additional resource for use in workshop settings, and/or self study. They consist of completed examples of selected pages from the PU/DR form. Completed examples can be used to: illustrate appropriate (or inappropriate) completion of specified fields. check for understanding, and highlight learning points. stimulate discussion and elicit additional examples, based on participant’s own grant data.
45
Slide 45 A. Impact / Outcome Indicators Impact / Outcome Indicator Description Baseline (if applicable) Year of Target Intended Target Report Due Date Actual Result Data Source of Results Comments on results on Impact/Outcome indicators and data sources, and any other comments ValueYear Impact % of adults and children with HIV still alive 12 months after initiation of antiretroviral therapy (extend to 2, 3, 5 years as program matures) 74.00 20012007 95.85 03/31/10 93.9 National Statistics Dirctorte AIDS clinical care database The target set is slightly under achieved. A total of 882 PLWHA out of 939 who initiated therapy between 1/Jan/2008 and 1/Dec/2008 were still alive and under treatment a year later, i.e. as of 31/Dec/2009. Among adults, the percentage stands at 93.88 (875/932); and among children, 100 (7/7). The denominator includes people who initiated therapy in the period and died by the end of 2009. Sources of data are the National Statistics Division at MINSAP and the Ficticia Institute. PR_Programmatic Progress_1A Completed example
46
Slide 46 LFA_Programmatic Progress_1A Completed example A. Impact / Outcome Indicators Impact / Outcome Indicator Description Year of Target Intended Target Report Due Date Actual Result (as reported by PR) Data Source of Results Verification Method Verified Result LFA comments on (a) verified result, (b) source of information used by the PR to report results, including the status of completion of surveys and other methods to measure Impact/Outcome, as applicable, Impact % of adults and children with HIV still alive 12 months after initiation of antiretroviral therapy (extend to 2, 3, 5 years as program matures) 2007 95.85 03/31/10 93.90 Other (type as appropriate) National Statistics Directorate, AIDS clinical care database Other … on site visit to *** Institute, and national surveillance system databases, including the clinical care (HMIS) database in MS Access, called SIDATRAT. 94 Indicator was calculated and reported following UNGASS Guidelines... We consider the program has reached the target set i.e. 98% of target (calculated as 94% actual against 96% target). These high results are in line with universal ARV access targets for Country X, which moreover reports high rate of adherence for ARV treatment (only 2% abandonment). LFA compared the verified result (94%) against that reported in UNGASS country report for the same year, which was 94,9%. Minor difference due to deaths notified after copy deadline for UNGASS report.
47
Slide 47 PR_Programmatic Progress_1B Completed example B. Programmatic Indicators Objective No. Indicator No. Indicator DescriptionTied To Targets cumulative? Top 10 ? Baseline (if applicable) Intended Target to date Actual Result to date % achieve- ment Reasons for programmatic deviation from intended target and deviations from the related workplan activities ValueYear 31 Number of social market condoms distributed in the City of La Cuidana and in 18 surrounding municipalities Current grant Y-over RCC term Yes 338,64480 2008 1,447,0001,424,864 98% The target is met. A total of 1,195,172 condoms were supplied from the central storage facility to the City of Cuidana and municipalities in this quarter, totaling 1,424,864. There are 1,244,800 units still to be sold under social marketing, out of 2,669,664 condoms that have been received to date. Out of this total, 245,271 units have been sold. Calculated in this example as actual result reported by PR/intended target x 100 = 98.4%
48
Slide 48 B. Programmatic Indicators Objec No. Indica tor No. Indicator Description Tied to Targets cumulative ? Top 10 ? Intended Target to date (from PF) Actual Result to date (reported by PR) Verific ation Metho d Verified Result % achieve ment LFA analysis on progress to date and any variance between targets and results, and any other comments 31 Number of social market condoms distributed in the City of La Cuidana and in 18 surrounding municipalties Current grant Y-over RCC term Yes - Top 10 1,447,0001,424,864 PR On- site Visit 759,58452% The difference between result reported by the PR and verified result is due to condoms distributed using Round 6 grant funds. A total of 665,280 condoms have been adjusted in the results for this RCC grant, as these were 'borrowed' from Round 6. The condoms reported are those distributed from central warehouse to provincial warehouses. LFA_Programmatic Progress_1B Completed example
49
Slide 49 Global Fund Management ActionsPR Comments on Progress of Implementation PR will submit a report on use of revenues from condom sales every six months, not later than 15 May 2010, along with the next progress report. In process. A local consultant was hired to develop a data collection system for condom-distribution-related expenses. A first report including the diagnosis conducted has already been prepared and is attached to this progress report. The system is expected to become operational at the beginning of the next semester. Section 2: Grant Management Completed example, management actions Global Fund Management ActionsLFA Review of PR Progress on Global Fund Management Actions PR will submit a report on the use of revenues from condom sales every six months, not later than 15 May 2010, along with the next progress report. There were delays in the selection of the local consultant, who will be responsible for identifying expenditures related to condom transportation, handling and storage, and designing a methodology for verifying these expenses. In addition, as the report on utilization of revenues obtained through social market condom sales will be semestral, reporting should commence next quarter i.e. the end of the first semester during which this system is due to be operational. PR data exported to LFA sheet
50
Slide 50 All amounts are in: USD LFA-Verified Budget for Reporting Period LFA- Verified Actual for Reporting Period Variance LFA Analysis of Variance LFA- Verified Cumulative Budget LFA-Verified Actual VarianceLFA Analysis of Variance 1. Total cash outflow vs. budget 264,195407,578-143,383 7,200,0004,000,0003,200,000 1a. PR's total expenditures 91,128130,993-39,865 The variance relates to overspending on salaries due to certain HR costs related to current quarter being mistakenly included in the next implementation quarter as part of the approved budget. This mistake has been pointed out to the PR and will be corrected at time of the next implementation letter. However, the mistake does not affect the total amount budgeted for HR costs in this grant as it is merely a shift between periods. 3,774,0683,417,384356,684 The underspending vs budget is made up of the following variances: HR 100k - underspending due to late hiring for ten positions (net of budget mistake identified in current period) Training (20k) – overspending due to higher fuel costs and increase in per-diems as per new government circular M&E 277k – underspending due to more efficient organization of supervision and quarterly review meetings LFA_Total PR Cash Outflow_3A Completed Example Note: Section on Disbursements to SRs has been excluded in this example
51
Slide 51 LFA_ Procurement Info_4 Completed example PR's response LFA's response Has the PR updated the Price Quality Reporting (PQR) with the required information…? N/A No products received during the reporting period, which had to be included in the PQR. Reporting Currency PQR Product Categories Value of products received during reporting period Value of products entered by the PR and verified as correct Variance Reason for Variance Cumulative value of products received since Jan 2011 Cumulative value of products verified as correct VarianceReason for Variance 4. Condoms 201,471.80183,201.9018,269.90 The cumulative value of products received includes figures reported in PU/DR; cumulative value of products verified reflects figures reported in the PQR. The amount of USD201K (voucher 41288) in the PU/DR corresponds to the value of condoms and lubricants received. Since lubricants valued at USD18K do not have to be reported in the PQR, the amount reported in the PQR reflects verified value of condoms received.
52
Slide 52 A. LFA-VERIFIED CASH RECONCILIATION FOR PERIOD COVERED BY PROGRESS UPDATE PR- reported amounts LFA- verified amounts LFA Comments (if amounts are different from those reported by the PR) 1. Cash Balance: Beginning of period covered by Progress Update 111,887 1,387,644 2. Cash received by the PR from the Global Fund 3.Cash disbursed to third parties by the Global Fund on behalf of the PR 050,000 The Global Fund has disbursed directly to GLC $50,000 during the period covered by this cash reconciliation. 4. Interest received on bank account 320 5. Revenue from income-generating activities 25,00020,000 Condom sales. However, the PR has incorrectly included revenues from the sale of ACTs (this is an HIV grant) 6.Other income, if applicable (e.g. income from disposal of fixed assets, tax refunds) 52,793 The PR has received a VAT tax refund which was duly recorded in the cash book, but inadvertently omitted it from this cash reconciliation. This VAT refund relates to the previous period in which the same amount was included as expenditures. Cumulative expenditures to-date should be reduced by the same amount. 7. Total PR cash outflow -460,371-407,578 The difference is due to GF not approving the purchase of additional vehicles in excess of budgeted quantities. 8. Net exchange rate gains/losses -15,000 The PR has lost in USD terms due to the depreciation of the local currency vs the USD (PR keeps cash balances in local currency). 9. Reconciliation adjustments 20,000 $20,000 are savings from previous periods which should be refunded by the procurement agent. 10. Cash Balance: 1,064,4801,220,066 LFA_Cash Reconciliation_5A Completed Example
53
Slide 53 LFA_Disbursement Recommend_5B Completed example 10. Period beginning date: 1-Apr- 2010 end date: 30-Sep- 2010 Approved budget amount (reported by PR): 2,000,000 Forecasted amount (reported by PR): 2,000,000 LFA-verified approved budget amount: 2,200,000 LFA-adjusted forecasted amount: 2,110,000 11. Additional quarter PR Total Forecast (cash "buffer") beginning date (3) : 1-Oct- 2010 end date: 31-Dec- 2010 Approved budget amount (reported by PR): 2,000,000 Forecasted amount (reported by PR): 2,215,000 4,215,000 LFA Total Forecast LFA-verified approved budget amount: 600,000 LFA-adjusted forecasted amount: 155,000 2,265,000 PR's explanation of any significant variance between forecasted amounts and amounts as originally budgeted. The forecast is based on approved and budgeted activities, including certain adjustments mainly for exchange rate impact, unspent funds from previous quarters and some re- allocations. See attached workings, Example Sheet A. LFA's explanation of any significant variance between forecasted amounts and amounts as originally budgeted. The forecasted amount proposed by the LFA, including a reconciliation versus PR’s workings, is included in attached Example Sheet A.
54
Slide 54 Section 6: LFA EVALUATION AND COMMENTS ON OVERALL PERFORMANCE A. Overall Evaluation and Rating of Grant Performance (including a summary of how financial performance is linked to programmatic achievements) Indicator ratingA1 Any major management issues resulting in downgrade?No Overall Grant RatingA1 Overall performance for this RCC program term is excellent, reaching a mean achievement rate of 113% for all Service Delivery Area indicators, and 98% for Top Ten/ To Ten equivalent indicators. However, Top Ten indicator 'Number of condoms distributed for free in the City of La Cuidana and surrounding provinces‘ remains below target. The results reported for this indicator were adjusted by LFA, as PR reports for this quarter, erroneously relate to condoms purchased under the Round 6 grant. In addition, distribution of condoms under the RCC term is based on installation and use of special dispensers, in new sites. The special dispensers have not yet been procured or installed. In contrast to programmatic achievement, financial absorption rate is not so high, at 74% cumulatively, since the start of the RCC program term. This is due to: savings in acquisition of condoms and lubricants at lower prices and delays in procurement of dispensers; delays in procurement of health equipment associated with Health Systems Strengthening (HSS) and the indicator 'Number of people reached in health services upgraded to include PLWHA care.‘ This indicator nonetheless exceeded programmatic targets, due to the fact that, of four out of six health centers which were upgraded, additional PLWHA patients were reached than originally targeted, in those sites. These results more than compensated for the two health centers which have not yet been upgraded, and where clinical care specific to PLWHA, remains limited. B. LFA comments on PR planned changes in the program, if any There are no planned changes to the program, and none required. C. LFA Comments on External Factors Beyond Control of the Principal Recipients that have impacted or may impact program The economic situation in County X is critical. Expected GDP for 2009 was 6%; in reality it dropped to 1.4% The country is experiencing difficulties in cancelling financial commitments. The foreign embargo continues to cause delays in procurement processes. Section 6: Overall Performance Completed example
55
Slide 55 LFA_Disbursement Recommendation_7 Completed example Overall RatingA2 Indicative disbursement ranges by performance rating Performance ratingRange for cumulative disbursement amount A1 Exceeding expectationsAbove 95% of cumulative budget through the next reporting period A2 Meeting expectationsBetween 85-105% of cumulative budget through the next reporting period B1 Adequate Between 55-95% of cumulative budget through the next reporting period B2 Inadequate but potential demonstratedBetween 25-65% of cumulative budget through the next reporting period C Unacceptable Below 35% of cumulative budget through the next reporting period 1. Cash amount requested by the Principal Recipient from the Global Fund for next disbursement period plus one additional quarter (amount in: please select currency in 'PR_Section 1A') 3,150,520 Three million, one hundred and fifty thousand, five hundred and twenty USD 2. LFA disbursement recommendation (amount in: please select currency in 'PR_Section1A') 1,044,934 One million, forty two thousand, nine hundred and thirty four USD State the amount in words Cumulative budget through the next period of implementation (including the buffer) Cumulative disbursed amount to date (*) Cumulative disbursed after recommended disbursement (including the buffer) % range Is the recommended disbursement within the range? 10,000,000 8,755,066 9,800,000 98% Yes (*)This data can be obtained from the "Disbursements in detail report (PDF)" (http://www.theglobalfund.org/documents/disbursementdetails.pdf) Sum of these =
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.